Digital transformation for global life science innovators


Kymab is a Cambridge-based biopharmaceutical company working to develop pioneering therapies and drive world-leading vaccine discovery - using a unique, world-leading platform to deliver human antibodies. Funded by some of science's most notable investment funds (The Wellcome Trust, The Bill and Melinda Gates Foundation) Kymab’s technology assures the highest likelihood of discovering best-in-class drug and vaccine candidates, using efficient technology to develop products in some of the world’s most challenging and important pharmaceutical areas.

Kymab appointed Onespacemedia to redesign and redeliver the company's website to use first-class design to reflect their best-in-class scientific work.



Kymab discovers and develops its drugs both independently and in collaboration with pharmaceutical, biotechnology and academic partners. With an ambitious growth target across a number of different therapeutic spaces, it was up to the Onespacemedia team to design a powerful but simple mechanism to communicate the value of the organisation's pipeline and the partners that Kymab work with.



Kymab have a strong identity founded on scientific excellence and the value of the organisation's world-leading scientific team. It was critically important to the project to generate a host of brand-new, Kymab-specific assets to distinguish themselves confidently in their space - and we commissioned, art directed and managed a photoshoot custom designed to deliver outstanding digital assets for the website and beyond. 


“Onespacemedia’s professional, knowledgeable and understanding approach was essential in helping Kymab to redevelop its website. They rapidly understood our requirements and audiences and developed approaches to satisfy them. Throughout the project all their staff were extremely helpful, going to great lengths to provide solutions to our requests. It was a pleasure to work with them and the outcome is excellent.”

Anne Hyland, CFO, Kymab

Visit website